MEDGENOME

MedGenome is a leader in genetic diagnostics, genomics research, and drug discovery solutions, founded in 2013 and based in Delaware, U.S. The company operates significant facilities in India, California, and Singapore, specializing in next-generation sequencing (NGS) technologies. MedGenome conducts over 375,000 genetic tests annually, serving more than 200,000 patients with the support of over 15,000 clinician partners. The company offers a wide range of services, including genetic testing and diagnostics, cancer diagnostics with proprietary solutions like OncoPept and OncoTrack, carrier screening for couples, non-invasive prenatal testing, and infectious disease testing. MedGenome operates a state-of-the-art NGS facility in California, equipped with advanced sequencing platforms. It adheres to international quality standards and has received multiple awards for its contributions to the diagnostics field. MedGenome also collaborates with pharmaceutical companies and has secured significant funding to support its growth and innovation initiatives.